Huang Xiao-Mei, Yu Fen, Wang Yin, Gu Lian-Qing, Xu Li, Fu Hui-Ling, Zhang Yi, Li Jing-Jing, Sun Xiao-Feng
Department of Nephrology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Ultrasound, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
J Vasc Surg. 2023 Aug;78(2):526-533. doi: 10.1016/j.jvs.2023.04.017. Epub 2023 Apr 20.
Arteriovenous fistula is the preferred vascular access for hemodialysis patients. High-flow arteriovenous fistula may cause high-output heart failure. Various procedures are used to reduce high-flow arteriovenous fistula. This study aimed to assess the efficacy of proximal artery restriction combined with distal artery ligation on flow reduction for high-flow arteriovenous fistula and on cardiac function and echocardiographic changes in patients undergoing hemodialysis.
A retrospective analysis was performed on data collected from the medical records of patients undergoing hemodialysis with heart failure and high-flow arteriovenous fistula between May 2018 and May 2021. Thirty-one patients were treated with proximal artery restriction (banding juxta-anastomosis of the proximal artery) combined with distal artery ligation (anastomosis distal artery ligation). Changes in the Acute Dialysis Quality Initiative Workgroup cardiac function class, blood pressure, and echocardiography before and 6 months after flow restriction were compared, and post-intervention primary patency was followed-up.
The technical success rate of the surgery was 100%, and no surgery-related adverse events occurred. Blood flow and blood flow/cardiac output decreased significantly after flow restriction. Blood flow decreased from 2047.21 ± 398.08 mL/min to 1001.36 ± 240.42 mL/min, and blood flow/cardiac output decreased from 40.18% ± 6.76% to 22.34% ± 7.21% (P < .001). Post-intervention primary patency of arteriovenous fistula at 6, 12, and 24 months was 96.8%, 93.5%, and 75.2%, respectively. The Acute Dialysis Quality Initiative Workgroup cardiac function class improved significantly after 6 months of flow restriction (P < .001). The systolic and diastolic left heart function improved, as evidenced by a significant decrease in left atrial volume index, left ventricular end-diastolic/end-systolic diameters, left ventricular end-diastolic volume, left ventricular mass index, cardiac output, and cardiac index and an increase in lateral peak velocity of longitudinal contraction, average septal-lateral s', and lateral early diastolic peak velocity after flow restriction (P < .05). Systolic pulmonary artery pressure decreased from 32.36 ± 8.56 mmHg to 27.57 ± 8.98 mmHg (P < .05), indicating an improvement in right heart function.
Proximal artery restriction combined with distal artery ligation effectively reduced the blood flow of high-flow arteriovenous fistula and improved cardiac function.
动静脉内瘘是血液透析患者首选的血管通路。高流量动静脉内瘘可能导致高输出量心力衰竭。人们采用了各种方法来减少高流量动静脉内瘘。本研究旨在评估近端动脉缩窄联合远端动脉结扎术对高流量动静脉内瘘血流量减少的效果,以及对接受血液透析患者心功能和超声心动图变化的影响。
对2018年5月至2021年5月期间患有心力衰竭和高流量动静脉内瘘的血液透析患者的病历数据进行回顾性分析。31例患者接受了近端动脉缩窄(近端动脉吻合口旁绑扎)联合远端动脉结扎(远端动脉吻合口结扎)治疗。比较流量限制前后急性透析质量倡议工作组的心功能分级、血压和超声心动图变化,并对干预后的初次通畅情况进行随访。
手术技术成功率为100%,未发生与手术相关的不良事件。流量限制后血流量和血流量/心输出量显著下降。血流量从2047.21±398.08 mL/min降至1001.36±240.42 mL/min,血流量/心输出量从40.18%±6.76%降至22.34%±7.21%(P<.001)。动静脉内瘘干预后6个月、12个月和24个月的初次通畅率分别为96.8%、93.5%和75.2%。流量限制6个月后,急性透析质量倡议工作组的心功能分级显著改善(P<.001)。左心收缩和舒张功能改善,表现为流量限制后左心房容积指数、左心室舒张末/收缩末内径、左心室舒张末容积、左心室质量指数、心输出量和心脏指数显著降低,纵向收缩外侧峰值速度、平均室间隔-外侧s'和舒张早期外侧峰值速度增加(P<.05)。收缩期肺动脉压从32.36±8.56 mmHg降至27.57±8.98 mmHg(P<.05),表明右心功能改善。
近端动脉缩窄联合远端动脉结扎可有效降低高流量动静脉内瘘的血流量并改善心功能。